However, the association of overexpression of NQO1 with poorer outcomes in certain cancer types36, 37 suggests that tumours can bypass the antiproliferative actions of NQO1, potentially through the activation of pro‐carcinogenic compounds.39 The gene discussed is NQO1; the disease is cancer.